Metropolis Healthcare Limited — Important, 22-03-2025: General Updates

Metropolis Healthcare has announced a board meeting for the allocation of equity shares to Core Diagnostics (Mauritius) Pvt. Ltd. as part of the acquisition of Core Diagnostics. The total purchase consideration includes a cash remittance, with INR 5 crores held as deferred consideration pending closing adjustments. As a result, Core Diagnostics is now a wholly-owned subsidiary, effective immediately. This strategic acquisition enhances Metropolis's market position and could positively influence investor sentiment by expanding its service offerings and operational scope, presenting growth opportunities in the healthcare sector.